MENU Quick Go

  • HOME
  • News
  • PharmAbcine Notice
PharmAbcine Notice
Dr. Lawrence Cher, principle investigator of Tanibirumab phase IIa recurrent GBM trial in Australia expose the interim data of the ongoing trial at ASCO 2017 Annual Meeting in Chicago on June 2-6, 2017.
Date 2017-05-10 Hit 424
Attach Files  
Dr. Lawrence Cher, principle investigator of Tanibirumab phase IIa recurrent GBM trial in Australia expose the interim data of the ongoing trial at ASCO 2017 Annual Meeting in Chicago on June 2-6, 2017.

https://am.asco.org/
List